{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal allo-hMSCs",
            "NStudiesAvail": 430108,
            "NStudiesFound": 14,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 14,
            "FieldList": [
                  "OutcomeClassDenomCountGroupId",
                  "OutcomeClassDenomCountValue",
                  "OutcomeClassDenomUnits",
                  "OutcomeClassTitle",
                  "OutcomeDenomCountGroupId",
                  "OutcomeDenomCountValue",
                  "OutcomeDenomUnits",
                  "OutcomeGroupDescription",
                  "OutcomeGroupId",
                  "OutcomeGroupTitle",
                  "OutcomeMeasureAnticipatedPostingDate",
                  "OutcomeMeasureCalculatePct",
                  "OutcomeMeasureDenomUnitsSelected",
                  "OutcomeMeasureDescription",
                  "OutcomeMeasureDispersionType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT05522569"
                        ]
                  },
                  {
                        "Rank": 2,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02675556"
                        ]
                  },
                  {
                        "Rank": 3,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03265808"
                        ]
                  },
                  {
                        "Rank": 4,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02398604"
                        ]
                  },
                  {
                        "Rank": 5,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02677350"
                        ]
                  },
                  {
                        "Rank": 6,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [
                              "Baseline",
                              "13-Month",
                              "Baseline",
                              "13-Month",
                              "Baseline",
                              "13-Month",
                              "Baseline",
                              "Month 13",
                              "Improved NYHA Class",
                              "No change in NYHA Class",
                              "Worsened NYHA Class"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeDenomCountValue": [
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "14",
                              "14"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million allogeneic human mesenchymal stem cells.\n\nAllo-hMSCs : Biological: Allogeneic human mesenchymal stem cells (Allo-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Allo-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Allo-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Allo-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.",
                              "Participants will receive an injection of 20 million, 100 million or 200 million autologous human mesenchymal stem cells.\n\nAuto-hMSCs : Biological: Autologous human mesenchymal stem cells (Auto-hMSCs) Participants will receive 40 million cells/mL delivered in either a dose of 0.5 mL per injection x 1 injection for a total of 0.2 x 10^8 (20 million) Auto-hMSCs, a dose of 0.5 mL per injection x 5 injections for a total of 1 x 10^8 (100 million) Auto-hMSCs, or a dose of 0.5 mL per injection x 10 injections for a total of 2 x 10^8 (200 million) Auto-hMSCs. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter."
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeGroupTitle": [
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs",
                              "Allo-hMSCs",
                              "Auto-hMSCs"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Percentage change from 13-months post-catheterization to baseline.",
                              "The Minnesota living with heart failure questionnaire uses a 6-point, zero to five, Likert scale. The total score is the sum of the 21 responses. The total score is considered the best measure of how heart failure and treatments impact a patients quality of life. The max score is 105, minimum score is 0. A lower score is considered a better quality of life."
                        ],
                        "OutcomeMeasureDispersionType": [
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval",
                              "95% Confidence Interval"
                        ],
                        "NCTId": [
                              "NCT01087996"
                        ]
                  },
                  {
                        "Rank": 7,
                        "OutcomeClassDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG004",
                              "OG005",
                              "OG006",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG004",
                              "OG005",
                              "OG006",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG004",
                              "OG005",
                              "OG006",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG004",
                              "OG005",
                              "OG006"
                        ],
                        "OutcomeClassDenomCountValue": [
                              "5",
                              "5",
                              "5",
                              "10",
                              "10",
                              "10",
                              "20",
                              "5",
                              "5",
                              "2",
                              "0",
                              "0",
                              "6",
                              "12",
                              "3",
                              "5",
                              "1",
                              "0",
                              "0",
                              "0",
                              "0",
                              "1",
                              "2",
                              "1",
                              "0",
                              "0",
                              "0",
                              "0"
                        ],
                        "OutcomeClassDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeClassTitle": [
                              "Infusion #1",
                              "Infusion #2",
                              "Infusion #3",
                              "infusion #4"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG004",
                              "OG005",
                              "OG006"
                        ],
                        "OutcomeDenomCountValue": [
                              "5",
                              "5",
                              "5",
                              "10",
                              "10",
                              "10",
                              "20"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Group 1 participants will receive Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs): 20 million allo-hMSCs/kg delivered via peripheral intravenous infusion. Participants in this group have the option to receive an additional 3 infusions of 100million allo-hMSCs/kg per infusion with a 12 to 18 month interval.\n\nAllogeneic Human Mesenchymal Stem Cells (allo-hMSCs): Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion",
                              "Group 2 - Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs): 100 million allo-hMSCs/kg delivered via peripheral intravenous infusion. Participants in this group have the option to receive an additional 3 infusions of 100million allo-hMSCs/kg per infusion with a 12 to 18 month interval.\n\nAllogeneic Human Mesenchymal Stem Cells (allo-hMSCs): Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion",
                              "Group 3 - Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs): 200 million allo-hMSCs/kg delivered via peripheral intravenous infusion. Participants in this group have the option to receive an additional 3 infusions of 100million allo-hMSCs/kg per infusion with a 12 to 18 month interval.\n\nAllogeneic Human Mesenchymal Stem Cells (allo-hMSCs): Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion",
                              "Group A - Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs): 100 million allo-hMSCs/kg delivered via peripheral intravenous infusion.\n\nAllogeneic Human Mesenchymal Stem Cells (allo-hMSCs): Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion",
                              "Group B - Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs): 200 million allo-hMSCs/kg delivered via peripheral intravenous infusion.\n\nAllogeneic Human Mesenchymal Stem Cells (allo-hMSCs): Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion",
                              "Group C - Placebo delivered via peripheral intravenous infusion. Participants in this group have the option to receive one additional infusion of 100million allo-hMSCs/kg with a 12 to 18 month interval.\n\nAllogeneic Human Mesenchymal Stem Cells (allo-hMSCs): Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion\n\nPlacebo: Placebo administered by peripheral intravenous infusion.",
                              "Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs): 100 million penicillin/streptomycin-free allo-hMSCs/kg delivered via peripheral intravenous infusion. Participants in this group have the option to receive an additional 3 infusions of 100million allo-hMSCs/kg per infusion with a 12 to 18 month interval.\n\nAllogeneic Human Mesenchymal Stem Cells (allo-hMSCs): Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion\n\nPenicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs): Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) administered by peripheral intravenous infusion."
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG004",
                              "OG005",
                              "OG006"
                        ],
                        "OutcomeGroupTitle": [
                              "Pilot Phase - Group 1",
                              "Pilot Phase - Group 2",
                              "Pilot Phase - Group 3",
                              "Randomized Phase - Group A",
                              "Randomized Phase - Group B",
                              "Randomized Phase - Group C",
                              "Addendum B - Antibiotic Free Cell Group"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeMeasureDescription": [
                              "Incidence of any treatment-emergent serious adverse events (SAE), defined as the composite of: death, non-fatal pulmonary embolism, stroke, hospitalization for worsening dyspnea and clinically significant laboratory test abnormalities.\n\nSerum chemistry: chloride, bicarbonate, blood urea nitrogen (BUN), creatinine, glucose, calcium, aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (fractionate if total >1.5 times normal), alkaline phosphatase, albumin,\nHematology (Complete blood count): hemoglobin, hematocrit, platelets, white blood cells (WBC), WBC differential",
                              "Community Healthy Activities Model Program for Seniors (CHAMPS) questionnaire measures duration of exercise-related activities (hours/week). The Duration variable can range from 0 - 399.75 hours per week. Higher scores indicate more activity.",
                              "4-meter gait speed test measures the time (in seconds) taken to walk a distance of 4 meters. The total score has a range of 1 point - 4 points with the higher score indicating faster walk speed.",
                              "Standard Physical Performance Battery (SPPB) Assessment has total score ranging from 0-4 with the higher score indicating better balance.",
                              "Change in weight as measured in kilograms (kg).",
                              "Hand grip strength as assessed by a dynamometer. Grip strength is recorded (in mmHg) three times for each hand. The average reading is reported for each hand.",
                              "Multi-dimensional Fatigue Inventory (MFI) Questionnaire contains 20 questions with a 5-point scale. The MFI has total score ranging from 20-100 with the higher score indicating less fatigue.",
                              "Investigating Choice Experiences for the Preferences of Older People (ICEpop) Capability measure for Older people (ICECAP) questionnaire has total score ranging from 5-20 with the higher score indicating greater quality of life.",
                              "Short Form (SF)-36 Questionnaire has consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale. Lower scores indicate the more disability, and higher scores indicate less disability.",
                              "EuroQoL (EQ)- 5 Dimension (5D)- 3 levels (3L) Questionnaire has total score ranging from 0-10 for the 5 dimensions. Higher scores indicate better Quality of Life.",
                              "EuroQoL - 5 Dimension - 3 levels (EQ-5D-3L) Overall health status question has a range of 0-100. Higher scores indicate better Quality of Life.",
                              "University of Pennsylvania Smell Identification Test (UPSIT) smell test booklet has a total score ranging from 0-40 with higher scores indicating better olfaction.",
                              "Any reported death from any cause.",
                              "Change in dobutamine stress echocardiogram induced ejection fraction",
                              "Change in inflammatory markers including C-Reactive Protein (CRP) and Fibrinogen serum samples as measured in mg/L.",
                              "Change in inflammatory markers including Interleukin (IL)-6 and Tumor Necrosis Factor (TNF) Alpha from serum samples as measured in pg/mL.",
                              "Change in inflammatory marker D-Dimer from serum samples as measured in mg/dL."
                        ],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02065245"
                        ]
                  },
                  {
                        "Rank": 8,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03487731"
                        ]
                  },
                  {
                        "Rank": 9,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT03058068"
                        ]
                  },
                  {
                        "Rank": 10,
                        "OutcomeClassDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003"
                        ],
                        "OutcomeClassDenomCountValue": [
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "2",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "4",
                              "3",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "2",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "4",
                              "3",
                              "3",
                              "2",
                              "5",
                              "5",
                              "2",
                              "2",
                              "5",
                              "5",
                              "2",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "2",
                              "3",
                              "5",
                              "5",
                              "1",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "4",
                              "3"
                        ],
                        "OutcomeClassDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeClassTitle": [
                              "Baseline",
                              "Day 3",
                              "Day 7",
                              "Day 14",
                              "Day 28",
                              "Day 90",
                              "Day 180",
                              "Day 365",
                              "Baseline",
                              "Day 3",
                              "Day 7",
                              "Day 14",
                              "Day 28",
                              "Day 90",
                              "Day 180",
                              "Day 365",
                              "Baseline",
                              "Day 3",
                              "Day 7",
                              "Day 14",
                              "Day 28",
                              "Day 90",
                              "Day 180",
                              "Day 365"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003"
                        ],
                        "OutcomeDenomCountValue": [
                              "3",
                              "3",
                              "5",
                              "5",
                              "3",
                              "3",
                              "5",
                              "5",
                              "0",
                              "0",
                              "0",
                              "0",
                              "0",
                              "0",
                              "0",
                              "0",
                              "3",
                              "3",
                              "5",
                              "5",
                              "0",
                              "0",
                              "0",
                              "0",
                              "3",
                              "3",
                              "5",
                              "5"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 20 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n20 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion",
                              "Participants in this group will receive one peripheral intravenous infusion of 100 million allogeneic Mesenchymal Human Stem Cells (hMSCs)\n\n100 million Allogeneic Mesenchymal Human Stem Cells: 1 single intravenous infusion"
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003",
                              "OG000",
                              "OG001",
                              "OG002",
                              "OG003"
                        ],
                        "OutcomeGroupTitle": [
                              "Pilot Phase 20 Million Allogeneic hMSCs",
                              "Pilot Phase 100 Million hMSCs",
                              "Randomized Phase 20 Million Allogeneic hMSCs",
                              "Randomized Phase 100 Million Allogeneic hMSCs",
                              "Pilot Phase 20 Million Allogeneic hMSCs",
                              "Pilot Phase 100 Million hMSCs",
                              "Randomized Phase 20 Million Allogeneic hMSCs",
                              "Randomized Phase 100 Million Allogeneic hMSCs",
                              "Pilot Phase 20 Million Allogeneic hMSCs",
                              "Pilot Phase 100 Million hMSCs",
                              "Randomized Phase 20 Million Allogeneic hMSCs",
                              "Randomized Phase 100 Million Allogeneic hMSCs",
                              "Pilot Phase 20 Million Allogeneic hMSCs",
                              "Pilot Phase 100 Million hMSCs",
                              "Randomized Phase 20 Million Allogeneic hMSCs",
                              "Randomized Phase 100 Million Allogeneic hMSCs",
                              "Pilot Phase 20 Million Allogeneic hMSCs",
                              "Pilot Phase 100 Million hMSCs",
                              "Randomized Phase 20 Million Allogeneic hMSCs",
                              "Randomized Phase 100 Million Allogeneic hMSCs",
                              "Pilot Phase 20 Million Allogeneic hMSCs",
                              "Pilot Phase 100 Million hMSCs",
                              "Randomized Phase 20 Million Allogeneic hMSCs",
                              "Randomized Phase 100 Million Allogeneic hMSCs",
                              "Pilot Phase 20 Million Allogeneic hMSCs",
                              "Pilot Phase 100 Million hMSCs",
                              "Randomized Phase 20 Million Allogeneic hMSCs",
                              "Randomized Phase 100 Million Allogeneic hMSCs"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "TE-SAEs as evaluated by the investigator which may include but not limited to: death, non-fatal pulmonary embolism, stroke, hospitalization for worsening dyspnea and clinically significant laboratory test abnormalities.",
                              "Endothelial Progenitor Cell Colony Forming Units (EPC-CFU) will be assessed from blood samples",
                              "C-Reactive Protein (CRP) levels will be assessed from blood samples and reported in mg/L",
                              "Circulating Angiogenic Factor levels including Vascular Endothelial Growth Factor (VEGF), Stem Cell Factor (SCF) and Stromal Cell-Derived Factor 1 (SDF-1) will be assessed from blood samples and reported in ng/mL",
                              "FMD will be assessed using brachial artery ultrasound",
                              "Circulating inflammatory marker levels including Interleukin (IL) -1 and IL-6 will be assessed from blood samples and reported in pg/mL",
                              "Measured from blood samples (pg/mL)"
                        ],
                        "OutcomeMeasureDispersionType": [
                              "Standard Deviation",
                              "Standard Deviation",
                              "Standard Deviation"
                        ],
                        "NCTId": [
                              "NCT02886884"
                        ]
                  },
                  {
                        "Rank": 11,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02013700"
                        ]
                  },
                  {
                        "Rank": 12,
                        "OutcomeClassDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeClassDenomCountValue": [
                              "15",
                              "15",
                              "12",
                              "13",
                              "15",
                              "15",
                              "12",
                              "13",
                              "15",
                              "15",
                              "14",
                              "12",
                              "13",
                              "14",
                              "15",
                              "15",
                              "14",
                              "15",
                              "14",
                              "14",
                              "14",
                              "14",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "14",
                              "15",
                              "15",
                              "15",
                              "15",
                              "14",
                              "14",
                              "15",
                              "15",
                              "14",
                              "14",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "14",
                              "14",
                              "14",
                              "15",
                              "14",
                              "14",
                              "13",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "12",
                              "14",
                              "12",
                              "14",
                              "12",
                              "14",
                              "14",
                              "13",
                              "15",
                              "15",
                              "14",
                              "14",
                              "15",
                              "15"
                        ],
                        "OutcomeClassDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeClassTitle": [
                              "Baseline",
                              "12 Months",
                              "at 6 months",
                              "at 12 months",
                              "Baseline",
                              "6 months",
                              "12 months",
                              "Baseline",
                              "3 months",
                              "6 months",
                              "12 months",
                              "Baseline to 3 months, Improved",
                              "Baseline to 3 months, Unchanged",
                              "Baseline to 3 months, Worsened",
                              "Baseline to 6 months, Improved",
                              "Baseline to 6 months, Unchanged",
                              "Baseline to 6 months, Worsened",
                              "Baseline to 12 months, Improved",
                              "Baseline to 12 months, Unchanged",
                              "Baseline to 12 months, Worsened",
                              "1 month from injection",
                              "6 months from injection",
                              "12 months from injection",
                              "Treatment emergent AE (6 month)",
                              "Treatment emergent AE (12 months)",
                              "Baseline",
                              "3 months",
                              "6 months",
                              "12 months",
                              "Month 6",
                              "Month 12",
                              "baseline, normal",
                              "baseline, abnormal not clinically significant",
                              "baseline, abnormal, clinically significant",
                              "12 months, normal",
                              "12 months, abnormal not clinically significant",
                              "12 months, abnormal, clinically significant",
                              "12-hours post-catheterization",
                              "24-hours post-catheterization",
                              "Normal",
                              "Abnormal, Not Clinically Significant",
                              "Abnormal, Clinically Significant",
                              "12 hour post catheterization",
                              "24 hour post catheterization"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeDenomCountValue": [
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "15",
                              "0",
                              "0",
                              "0",
                              "0",
                              "0",
                              "0",
                              "12",
                              "13",
                              "0",
                              "0",
                              "0",
                              "0",
                              "12",
                              "13",
                              "0",
                              "0",
                              "15",
                              "15",
                              "0",
                              "0",
                              "15",
                              "15",
                              "7",
                              "8",
                              "15",
                              "15"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 4 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 0.2x 10^8 (20 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection",
                              "Fifteen (15) patients to be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1x 10^8 (100 million) Allo-hMSCs.\n\nAllogeneic hMSCs: Allogeneic Adult Human Mesenchymal Stem Cells (MSCs) delivered via injection"
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeGroupTitle": [
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs",
                              "Group 1: 20 Million Allogeneic hMSCs",
                              "Group 2: 100 Million Allogeneic hMSCs"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Incidence (at one month post-catheterization) of any treatment-emergent serious adverse events, defined as the composite of: death, non-fatal MI, stroke, hospitalization for worsening heart failure, cardiac perforation, pericardial tamponade, sustained ventricular arrhythmias (characterized by ventricular arrhythmias lasting longer than 15 seconds or with hemodynamic compromise).",
                              "Determined by delayed contrast enhanced Computed Tomography (CT) Scan",
                              "Tissue perfusion measured by CT.",
                              "Peak VO2 assessed via treadmill determination.",
                              "A test that measures how far a patient can walk in 6 minutes.",
                              "Changed in NYHA Functional Classification will be evaluated. Worsened: Documented increase in limitation in physical activity. Improved: Documented decrease in limitation in physical activity. Unchanged: No documented change in limitation in physical activity.",
                              "Incidence of the Major Adverse Cardiac Events (MACE) endpoint, defined as the composite incidence of (1) death, (2) hospitalization for worsening heart failure, or (3) non-fatal recurrent MI.",
                              "Incidence of Treatment Emergent Adverse Event defined as any untoward medical occurrence in a patient or clinical investigation subject temporally associated with the use of the study product.",
                              "Minnesota Living with Heart Failure (MLHF) Questionnaire has a total score from 0 to 105. A higher score indicates that participant's heart failure is preventing them from living their life.",
                              "Left ventricular end diastolic wall thickness as determined by echocardiogram.",
                              "As determined by Computed Tomography Scan",
                              "As determined by Computed Tomography Scan",
                              "As determined by Computed Tomography Scan",
                              "Change in 1-year LVEF by CT as compared to baseline.",
                              "As assessed via ECHO",
                              "Difference in left ventricular end diastolic and end systolic volume will be assessed via ECHO",
                              "Difference in left ventricular end diastolic and end systolic volume will be assessed via CT",
                              "As measured via myocardial mass by CT",
                              "The number of participants with abnormal ECG readings via 24 hour ambulatory ECG recordings as assessed per treating physician discretion.",
                              "Clinical significance of abnormal lab values will be assessed by treating physician",
                              "Serial Troponin I values in ng/mL over time.",
                              "The number of participants with abnormal reading post-cardiac catheterization. As assessed per treating physician discretion.",
                              "CK-MB values in ng/mL over time."
                        ],
                        "OutcomeMeasureDispersionType": [
                              "Inter-Quartile Range",
                              "Standard Deviation",
                              "Standard Deviation",
                              "Inter-Quartile Range",
                              "Inter-Quartile Range",
                              "Full Range",
                              "Full Range",
                              "Full Range",
                              "Full Range"
                        ],
                        "NCTId": [
                              "NCT02013674"
                        ]
                  },
                  {
                        "Rank": 13,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [
                              "Upper respiratory tract infection",
                              "Ventricular tachycardia",
                              "Device Pacing issue",
                              "Peak VO2 (Baseline)",
                              "Peak VO2 (6 months)",
                              "Peak VO2 (1 year)",
                              "6 minute walk (Baseline)",
                              "6 minute walk (6 months)",
                              "6 minute walk (1 year)",
                              "Global ejection fraction (Baseline)",
                              "Global ejection fraction (1 year)",
                              "NYHA Class 1 (Baseline)",
                              "NYHA Class 2 (Baseline)",
                              "NYHA Class 3 (Baseline)",
                              "NYHA Class 1 (6 month)",
                              "NYHA Class 2 (6 month)",
                              "NYHA Class 3 (6 month)",
                              "NYHA Class 1 (12 month)",
                              "NYHA Class 2 (12 month)",
                              "NYHA Class 3 (12 month)",
                              "MLHF (Baseline)",
                              "MLHF (6 month)",
                              "MLHF (12 month)"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeDenomCountValue": [
                              "16",
                              "18",
                              "16",
                              "18",
                              "16",
                              "18",
                              "16",
                              "18",
                              "18",
                              "19",
                              "16",
                              "18"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAutologous hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 1 (18 patients) Eighteen (18) patients will be treated with Auto-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.",
                              "Group 2 (18 patients) Eighteen (18) patients will be treated with allogeneic hMSCs (Allo-hMSCs): 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs.\n\nAllogeneic hMSCs: Cells will be administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested in 18 patients via transendocardial injection:\n\nGroup 2 (18 patients) Eighteen (18) patients will be treated with Allo-hMSCs: 20 million cells/ml delivered in a dose of 0.5 ml per injection x 10 injections for a total of 1 x 108 (100 million) Auto-hMSCs."
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeGroupTitle": [
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs",
                              "Autologous hMSCs",
                              "Allogeneic hMSCs"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Incidence of TE-SAEs is defined as the composite of: death, non-fatal MI, stroke, hospitalization for worsening heart failure, cardiac perforation, pericardial tamponade, sustained ventricular arrhythmias (characterized by ventricular arrhythmias lasting longer than 15 seconds or with hemodynamic compromise), or any other potential late effects detected and corroborated by clinical presentation, laboratory investigations, image analysis and when necessary with biopsy from suspected target sites in the body.",
                              "Measurement of Peak oxygen consumption (Peak VO2) by treadmill determination during the 12 month follow-up period.",
                              "Measurement of Six-minute walk test during the 12 month follow-up period",
                              "Measurement of regional left ventricular function, end diastolic and end systolic volume, measured by MRI, and or CT, and echocardiogram.",
                              "Measurement of New York Heart Association (NYHA) functional class during the 12 month follow-up period.",
                              "Measurement of Minnesota Living with Heart Failure (MLHF) Questionnaire during the 12 month follow-up period. It measures the effects of symptoms, functional limitations, and psychological distress on an individual's quality of life. The response scale for all 21 items on the MLHF is based on a 6-point. The Maximum possible scores being 126 and the minimum 0. Higher scores indicate a worse or worsening quality of life, while lower scores or decreasing scores indicate a better quality of life."
                        ],
                        "OutcomeMeasureDispersionType": [
                              "Standard Deviation",
                              "Standard Deviation",
                              "Standard Deviation",
                              "Full Range"
                        ],
                        "NCTId": [
                              "NCT01392625"
                        ]
                  },
                  {
                        "Rank": 14,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04476901"
                        ]
                  }
            ]
      }
}